In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Henry Schein’s current price trails the high-confidence PERT fair value by 7.8%, indicating slight undervaluation with wide valuation method spread. Financial health scores reveal strong profitability but weak growth and leverage metrics, increasing risk. Monte Carlo analysis shows high volatility and downside risk (63.9%), implying elevated uncertainty around the price.